home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

220 rows where filing_period = "third_quarter", filing_year = 2013 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 220 ✖

filing_year 1

  • 2013 · 220 ✖

filing_period 1

  • third_quarter · 220 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1420604 CEPHEID ff817a32-76d4-42f1-a227-410d397a89d9 Q3 CEPHEID 400270233 CEPHEID 2013 third_quarter MED See page fiveLobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE   70000 0 0 2013-07-19T17:33:37.777000-04:00
1437060 COLBY & COMPANY 3ef432c3-6944-47f0-af9d-b907ecf75162 Q3 COLBY & COMPANY 400394858 BIOOHIO 2013 third_quarter MED Repeal of medical device tax. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-09-17T10:29:14.803000-04:00
1437324 MARSHALL BRACHMAN a47e0983-f7fe-43f8-92a4-8f835703b840 Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2013 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2013-10-01T00:05:02.943000-04:00
1437438 HARRISON RIVARD DUNCAN & BUZZETT, CHTD. 1049d728-2540-4b8d-b1dc-4c91a3f68539 Q3 HARRISON RIVARD DUNCAN & BUZZETT, CHTD. 72257 HCA HEALTHCARE 2013 third_quarter MED Health and Medical Issues       0 0 2013-10-01T12:18:53.873000-04:00
1437777 THE PETRIZZO GROUP, INC. 55daa09c-5161-43e5-88e2-bc63c37759b7 Q3 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2013 third_quarter MED Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. Support for full funding of NIH HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 20000   0 0 2013-10-02T19:15:40.693000-04:00
1437778 THE PETRIZZO GROUP, INC. ec7f601f-3819-44c9-ba5b-29e408a90c9c Q3 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2013 third_quarter MED Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding. Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-02T19:17:41.690000-04:00
1437833 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) ecb29a32-0b8d-4e1c-84f4-44c19f921175 Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2013 third_quarter MED All matters dealing with pharmaceutical labeling Food & Drug Administration (FDA) 25000   0 0 2013-10-03T10:39:20.723000-04:00
1437837 PALMETTO GROUP 516e1af0-9e22-499e-9002-389b63e62538 Q3 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2013 third_quarter MED Federal Funding of AIDS vaccine Department of State, Foreign Operations, and Related Programs Appropriations Act, 2014 SENATE 22500   0 0 2013-10-03T11:05:24.630000-04:00
1437911 FEDERAL SOLUTIONS, LLC fa4d5e4b-87ae-4ef3-8a46-18aff5af9d86 Q3 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2013 third_quarter MED Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-03T13:47:10.590000-04:00
1437931 FEDERAL SOLUTIONS, LLC 081b91b7-5650-430f-8e00-046b54f6bd96 Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2013 third_quarter MED Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2013-10-03T13:52:15.867000-04:00
1437965 GRIZZLE COMPANY 27bdcad6-1171-4650-aafe-38b52e3dde99 Q3 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2013 third_quarter MED Support for PICORI grant application. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-03T14:37:32.067000-04:00
1438061 AMERICAN COLLEGE OF CLINICAL PHARMACY 6ed427b5-52d2-46cd-89ad-983cceb8d0a0 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2013 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   111725 0 0 2013-10-04T09:57:27.077000-04:00
1438222 THE PETRIZZO GROUP, INC. 5b70b2ff-25ea-4636-9285-f8658a604333 Q3 THE PETRIZZO GROUP, INC. 305932 VULCAN INC -- A PAUL G ALLEN COMPANY 2013 third_quarter MED Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2013-10-06T09:39:32.187000-04:00
1438231 THE PETRIZZO GROUP, INC. d320c9c8-4f09-4998-b6d1-f37625b916cc Q3 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2013 third_quarter MED Advocate for federal funding for reaserch on traumatic brain injury, PTSD, and treatment of bleeding during surgery and trauma. Defense, Dept of (DOD) 30000   0 0 2013-10-06T10:18:35.297000-04:00
1438962 ROCK & ASSOCIATES 2401e3b7-3900-4465-8fbe-d8506eacb1e6 Q3 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T15:05:41.507000-04:00
1438997 ROCK & ASSOCIATES 407d1250-c99d-4a09-9f06-d1b3569776b2 Q3 ROCK & ASSOCIATES 33545 CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-08T16:17:03.940000-04:00
1439022 ROCK & ASSOCIATES 2efc8e48-038e-47f8-9779-fedb2371ef54 Q3 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:25:12.103000-04:00
1439033 ROCK & ASSOCIATES 9128610a-95d7-427a-87ab-8fde1303fb55 Q3 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:37:20.167000-04:00
1439054 ROCK & ASSOCIATES b6a474f2-50c7-40de-b5aa-797e3d39a188 Q3 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:47:28.187000-04:00
1439066 ROCK & ASSOCIATES 77b91e60-fecc-4557-b3a9-32df69be9c13 Q3 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:56:37.737000-04:00
1439257 ASSN OF MEDICAL DEVICE REPROCESSORS 65eff704-7209-498d-adb9-90042d4cec2d Q3 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2013 third_quarter MED Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Contacted VA and House and Senate about regulations for reprocessed single-use medical devices. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)     0 0 2013-10-09T10:36:23.560000-04:00
1439394 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b5e58c43-41f1-488b-bb6f-ad49aff7858d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2013 third_quarter MED Appropriations and Authorization legislation for FY 2014 in health care HR 2397 Department of Defense Appropriations Bill 2014 and Senate bill HR 2216 Military Construction and Veterans Affairs Appropriations Bill FY2014 and Senate bill Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2013-10-09T12:49:35.297000-04:00
1439658 MCDERMOTT WILL & SCHULTE LLP 7d5efd10-88c0-4ff2-9c7f-68d2de6f3d3e Q3 MCDERMOTT WILL & SCHULTE LLP 24338 COALITION FOR 21ST CENTURY MEDICINE 2013 third_quarter MED Issues concerning regulation of laboratory tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2013-10-09T15:36:46.300000-04:00
1439677 MCDERMOTT WILL & SCHULTE LLP 5b8532e7-619c-44e1-935f-c37447d79c84 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2013 third_quarter MED FDA regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-09T15:42:54.403000-04:00
1439943 AMERICAN SOCIETY FOR MICROBIOLOGY ba9e9e3b-43be-4542-b513-5693d8b21aca Q3 AMERICAN SOCIETY FOR MICROBIOLOGY 3355 AMERICAN SOCIETY FOR MICROBIOLOGY 2013 third_quarter MED Laboratory Test Reimbursement Centers For Medicare and Medicaid Services (CMS)     0 0 2013-10-10T10:13:21.720000-04:00
1439989 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 73532052-e8ed-4857-87e5-3ddf54c14af8 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2013 third_quarter MED * AACC joined with other laboratory groups in writing to the HHS OIG raising concerns regarding the findings of a June 2013 OIG report on laboratory reimbursement. * AACC joined with other laboratory groups in writing to CMS in opposition to proposed cuts in pathology reimbursement rates outlined in the July 19, 2010 Physician Feee Schedule Proposed Rule for CY 2014. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),SENATE     0 0 2013-10-10T11:14:44.303000-04:00
1440001 LNE GROUP a8eb516c-8095-4d77-9ca9-10b7eb01e952 Q3 LNE GROUP 308811 GOJO INDUSTRIES 2013 third_quarter MED Lobbied on issues regarding medical industry HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-10T11:15:49.617000-04:00
1440048 LNE GROUP 4ca310bf-f382-41d8-9d19-5ef161391873 Q3 LNE GROUP 308811 ZIMMER 2013 third_quarter MED Lobbied for medical device issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-10T11:29:08.210000-04:00
1440065 RUBICON ADVISORS, LLC e73068e4-4714-4f9c-bd6e-001cae3f3d83 Q3 RUBICON ADVISORS, LLC 315091 COLLEGE OF AMERICAN PATHOLOGISTS 2013 third_quarter MED Physician Payment rates, Electronic Health Records Incentives Program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-10T11:39:13.637000-04:00
1440107 COVINGTON & BURLING LLP d21d5593-f175-43bc-bf5a-9cf7aa8f1961 Q3 COVINGTON & BURLING LLP 11195 AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) 2013 third_quarter MED FDA proposal to regulate clinical laboratory testing. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-10T12:48:42.867000-04:00
1440615 LNE GROUP d1f205c0-a221-4dff-993c-424c18d99fcf Q3 LNE GROUP 308811 INTRINSIQ MATERIALS 2013 third_quarter MED Lobbied for issues regarding the medical research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-11T09:52:23.303000-04:00
1440704 LNE GROUP ca3996fc-5149-42e0-af79-5ee00c16c240 Q3 LNE GROUP 308811 PARKER HANNIFIN 2013 third_quarter MED Lobbied on issues regarding the medical field/disease research/clinical labs HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2013-10-11T11:04:19.600000-04:00
1441107 PARRY, ROMANI, DECONCINI & SYMMS c349c190-9624-4f4c-b560-79e784787cc2 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2013 third_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014. Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-11T14:38:28.513000-04:00
1441210 CALIFORNIA LIFE SCIENCES a231f537-cf21-43af-a2e7-a4f56ac12c4a Q3 CALIFORNIA LIFE SCIENCES 7758 CALIFORNIA LIFE SCIENCES 2013 third_quarter MED Support NIH research funding. HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2013-10-11T15:39:28.097000-04:00
1441282 PARRY, ROMANI, DECONCINI & SYMMS ef6c3927-4d9e-4d59-86a6-3aa4ac640635 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2013 third_quarter MED Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-11T16:36:10.343000-04:00
1441392 CHARLIE MCBRIDE ASSOCIATES 0311dba2-42e8-44c8-bc03-151b496616e8 Q3 CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2013 third_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 7200   0 0 2013-10-11T17:57:15.280000-04:00
1441469 BEN BARNES GROUP LP a91c4b8f-2735-4b0a-b4ed-64fac0854d96 Q3 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2013 third_quarter MED Cancer research SENATE 75000   0 0 2013-10-12T14:15:58.537000-04:00
1441507 BEN BARNES GROUP LP 39e218e3-50ed-4dfa-ba85-16dec6bb1ab5 Q3 BEN BARNES GROUP LP 5415 ROYALTY PHARMA - / RP MANAGEMENT, LLC 2013 third_quarter MED Tax Reform, Master Limited Partnership HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2013-10-12T15:42:24.920000-04:00
1441519 BEN BARNES GROUP LP 54a6caf2-3e87-4738-9631-d3782b6e0735 Q3 BEN BARNES GROUP LP 5415 TEXAS A&M SYSTEM 2013 third_quarter MED Assist the Texas A&M System in pursuit of various projects, general government relations HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2013-10-12T16:09:34.093000-04:00
1441593 RAY C CULVER III 4990bbd6-3b3c-4835-b792-101a624c561a Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2013 third_quarter MED Funding for the USDA ARS human nutrition centers in the FY14 Agricultural Appropriations bills, HR 2410 and S 1244. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-13T23:46:00.303000-04:00
1441600 SRI INTERNATIONAL bd8deaf4-61b7-4baf-b089-61a40c560d84 Q3 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2013 third_quarter MED House and Senate FY14 Labor/HHS/Education Appropriations HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2013-10-14T08:39:09.867000-04:00
1441659 DANIELLE ORGAN PETERS 6181a8ee-1591-4bb8-bd9b-2b3bcd7b9edd Q3 DANIELLE ORGAN PETERS 400427062 CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP 2013 third_quarter MED Public policy to incentivize antibiotic drug development and innovation HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-14T10:14:44.090000-04:00
1441704 THE CJR GROUP, INC. 2d3bdb75-3a73-4fde-ad38-16c459a308e4 Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2013 third_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-14T10:58:07.857000-04:00
1441774 HOLLAND & KNIGHT LLP cc1d22b7-85a5-4acd-adf7-cec3c2361a7c Q3 HOLLAND & KNIGHT LLP 18466 PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION 2013 third_quarter MED Over the counter drug approval process for sunscreen ingredients; H.R. 2410, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2013-10-14T11:56:47.723000-04:00
1441985 WAKE FOREST UNIVERSITY HEALTH SCIENCES 5199b1e5-bada-4e54-ad06-c703a59f34a0 Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2013 third_quarter MED NIH Budget including Title VII & VIII programs-Sequestration-C.R. Debt Ceiling Negotiations Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   145000 0 0 2013-10-14T15:35:24.480000-04:00
1442413 HOLLAND & HART LLP 506a6e7e-966b-47f5-925c-4da48f25a09c Q3 HOLLAND & HART LLP 18444 TOURO UNIVERSITY 2013 third_quarter MED Monitor legislation affecting Graduate Medical Education; H.R. 1201-Training Tomorrows Doctors Today Act; HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-15T10:27:06.113000-04:00
1442556 GOLDBUG STRATEGIES LLC 89c75220-1894-4fdf-bc81-d65d75383bbf Q3 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2013 third_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-15T11:38:16.050000-04:00
1442560 ROCK & ASSOCIATES b85f9265-d81d-4734-880d-b35817d2897e Q3 ROCK & ASSOCIATES 33545 US COMPOUNDING 2013 third_quarter MED S.959, H.R. 3089 & H.R. 3204 legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-15T11:41:18.690000-04:00
1442583 GOLDBUG STRATEGIES LLC 07ad00ef-4048-4275-9e53-6f50abfc643a Q3 GOLDBUG STRATEGIES LLC 400701094 GENOMIC HEALTH INC. 2013 third_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-15T11:45:28.473000-04:00
1442601 GOLDBUG STRATEGIES LLC 4c74e4a4-775c-4ff1-953e-71bad529cbc7 Q3 GOLDBUG STRATEGIES LLC 400701094 LIFE TECHNOLOGIES/THERMO FISHER 2013 third_quarter MED regulation of medical devices, in vitro diagnostics and laboratory developed tests Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-15T11:55:37.770000-04:00
1442780 TURNER & GOSS LLP 9b52ea86-7bc8-4635-aa8b-84fe1787b56e Q3 TURNER & GOSS LLP 316310 CYSTIC FIBROSIS FOUNDATION 2013 third_quarter MED Proposals related to Food and Drug Administration standards for accelerated approval of new products HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-15T13:48:19.597000-04:00
1442968 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 71657f8e-81e6-4fab-a01a-6a3614f60efa Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2013 third_quarter MED No HR #/S. 1284, Labor-HHS-Education Appropriations Bill, FY 2014, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention HR 2397/ S 1429, Defense Appropriations, FY 2014 Defense health programs, Tuberous Sclerosis Complex Research Program Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-15T15:22:43.737000-04:00
1443057 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bdafac9a-fdfc-4a1a-bbaa-55e03724f9a9 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2013 third_quarter MED Research in hematology Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2013-10-15T15:49:16.440000-04:00
1443082 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 609c813e-19ba-4b4f-b421-67fedd99518d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2013 third_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2013-10-15T15:55:30.330000-04:00
1443098 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 90066502-dc56-4fdb-a88a-79e5273adaf0 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2013 third_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2013-10-15T15:58:41.567000-04:00
1443167 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. aa121ae6-fe11-486b-b756-aafb248788d9 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION OF AMERICA'S BLOOD BANKS 2013 third_quarter MED Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-15T16:12:02.877000-04:00
1443173 WEBMD HEALTH CORP. f68ac219-49a2-4374-9acc-9002d7dbd64a Q3 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2013 third_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records SENATE   30000 0 0 2013-10-15T16:13:04.660000-04:00
1443231 THOMPSON HINE LLP d635ac6c-5b66-4173-947f-c118d27bff34 Q3 THOMPSON HINE LLP 38051 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2013 third_quarter MED Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-15T16:34:32.113000-04:00
1443566 UNIVERSITY OF IOWA 889ca90c-f37f-416c-bc87-65c3f45d68c2 Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2013 third_quarter MED FY 2012 Appropriations Residency Caps Minority Improvement NIOSH Education and Research Centers for Occupational Health and SafetyPrevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations FY 2014 Appropriations Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   85562 0 0 2013-10-16T10:02:14.043000-04:00
1443691 POLICY DIRECTIONS INC. a4cd75e2-f4f8-4e68-865b-30f57a6eecdb Q3 POLICY DIRECTIONS INC. 31747 CHARLES RIVER LABORATORIES 2013 third_quarter MED Pre-clinical research models and drug discovery, development and testing. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-16T10:39:15.747000-04:00
1443806 THE CONAFAY GROUP, LLC 056638a8-b0dc-439f-a9e3-b7be1236488e Q3 THE CONAFAY GROUP, LLC 401004840 CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP 2013 third_quarter MED Improving the enviroment for antibiotic drug development HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2013-10-16T11:08:09.340000-04:00
1443944 K&L GATES, LLP fef2241a-df4b-44b5-bceb-0012ab250e80 Q3 K&L GATES, LLP 32098 SMITS SPEIDELL CONSULTING 2013 third_quarter MED Yet to be introduced: A bill to amend the Internal Revenue Code of 1986 to broaden the special rules for certain governmental plans under section 105(j) to include plans established by political subdivisions. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-16T11:47:22.760000-04:00
1444084 PRIME POLICY GROUP 1e4eb96e-180c-4906-be93-82f31d02a5ac Q3 PRIME POLICY GROUP 400532589 GLAXOSMITHKLINE 2013 third_quarter MED Medicare Part D HOUSE OF REPRESENTATIVES 40000   0 0 2013-10-16T12:37:41.807000-04:00
1444136 PERSONALIZED MEDICINE COALITION 04ff1975-3e7d-42c4-9359-a0835a19f1c8 Q3 PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2013 third_quarter MED Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2013-10-16T13:07:04.273000-04:00
1444317 THE OUTLAW GROUP e19a659d-37b5-4f1c-bd25-0c568a24d0f1 Q3 THE OUTLAW GROUP 46095 AMERICAN TINNITUS ASSOCIATION 2013 third_quarter MED Legislation to promote enhanced research into tinnitus by the National Institutes of Health and ohter general legislation of interest to tinnitus researchers and patients. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-16T14:23:37.927000-04:00
1444324 SQUIRE PATTON BOGGS cc685908-b9c4-420a-ba88-1142cbe1b3ef Q3 SQUIRE PATTON BOGGS 30906 SST, SHOTSPOTTER, INC. 2013 third_quarter MED Issues related to health as a result of illegal gun violence. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE 60000   0 0 2013-10-16T14:26:42.273000-04:00
1444425 THEODOSIOU CONSULTANTS 57434c5c-5b66-49a6-bb07-e0633fb0a7b3 Q3 THEODOSIOU CONSULTANTS 54621 THEODOSIOU CONSULTANTS 2013 third_quarter MED Medical Device Excise Tax, Clinical Trials Cancer Research Administration for Children & Families (ACF),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-16T14:56:01.180000-04:00
1444461 THEODOSIOU CONSULTANTS a6ba4539-6e04-46f0-9320-1a26f9cc5974 Q3 THEODOSIOU CONSULTANTS 54621 VIATRONIX INCORPORATED 2013 third_quarter MED Reimbursement HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-16T15:10:09.820000-04:00
1444515 INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS de706dfd-1115-42a0-937a-604b3b0784d9 Q3 INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS 19822 INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS 2013 third_quarter MED The IBEW along with the AFL-CIO lobbied congress against changing the Medicare eligibility age and means testing of the Medicare program. Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   247461 0 0 2013-10-16T15:21:10.727000-04:00
1444761 FORBES-TATE fbb11de9-31b4-4b5c-8ee7-80c02400b4c0 Q3 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2013 third_quarter MED Issues related to Medicare and Medicaid payments to physicians; issues related to medical imaging; issues related to Sustained Growth Rate (SGR). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-16T16:16:36.630000-04:00
1444832 INTERNATIONAL MYELOMA FOUNDATION ebb7a49a-b2f0-48c4-87b3-f0d5a7cd7410 Q3 INTERNATIONAL MYELOMA FOUNDATION 400595820 INTERNATIONAL MYELOMA FOUNDATION 2013 third_quarter MED HR 1801, Cancer Drug Coverage Parity Act HOUSE OF REPRESENTATIVES,SENATE   54000 0 0 2013-10-16T16:38:05.723000-04:00
1444923 WILLIAMS MULLEN eb917ee4-e167-41d5-a483-604c72b613d9 Q3 WILLIAMS MULLEN 47201 OWENS & MINOR 2013 third_quarter MED Issues related to medical supplies HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-16T17:10:53.163000-04:00
1444935 BRACEWELL LLP 60f5e68a-88ca-4aae-b17d-76620114e076 Q3 BRACEWELL LLP 6837 AIR LIQUIDE USA LLC 2013 third_quarter MED Work related to medical gases Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of 60000   0 0 2013-10-16T17:20:00.943000-04:00
1445062 STANFORD UNIVERSITY 8e0b593a-5983-46e9-a7d0-34790a8421c6 Q3 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2013 third_quarter MED Health Professional Programs Graduate Medical Education Funding Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE   80000 0 0 2013-10-16T17:49:15.787000-04:00
1445324 VAN SCOYOC ASSOCIATES 0c7a6e4f-6d8e-4d31-a3a4-e807ad03b600 Q3 VAN SCOYOC ASSOCIATES 39837 FLORIDA INTERNATIONAL UNIVERSITY 2013 third_quarter MED Medical research and Community Health Center related issues and initiatives. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-17T05:27:11.587000-04:00
1445355 VAN SCOYOC ASSOCIATES 36f0b1ba-d098-410d-b073-548e817f8504 Q3 VAN SCOYOC ASSOCIATES 39837 MEDICAL UNIVERSITY HOSPITAL AUTHORITY 2013 third_quarter MED Medical research and development related issues. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-17T06:03:27.300000-04:00
1445652 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) e0c21477-4340-439f-b186-7707bb7a84fe Q3 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2013 third_quarter MED Issues related to Federally sponsored research including NIH and DoD Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   249964 0 0 2013-10-17T09:32:42.567000-04:00
1445683 PARALYZED VETERANS OF AMERICA ce6db379-9ec5-4cf2-ba35-17217dc5f0ef Q3 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2013 third_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   85456 0 0 2013-10-17T09:40:51.117000-04:00
1445790 THEODOSIOU CONSULTANTS f05e97bb-47cb-4278-96b8-790e410004b2 3A THEODOSIOU CONSULTANTS 54621 VIATRONIX INCORPORATED 2013 third_quarter MED Reimbursement HOUSE OF REPRESENTATIVES,SENATE 36899   0 0 2013-10-17T10:11:42.680000-04:00
1445792 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 13f7b4f2-8982-4b27-b35f-314bbee5e080 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2013 third_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; HR 1309: Health Information Technology Reform Act HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013 Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 30000   0 0 2013-10-17T10:12:37.400000-04:00
1445813 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 72ddcd80-c2a4-4ebf-834f-f9fddb5159ca Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2013 third_quarter MED Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2013-10-17T10:16:47.290000-04:00
1445821 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e27dac4b-fd37-411a-8cc6-6ddeb9080b82 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 INTERNATIONAL MYELOMA FOUNDATION 2013 third_quarter MED Cancer Drug Coverage Parity Act, H.R. 1801 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-17T10:19:51.710000-04:00
1445976 NATIONAL ASSOCIATION OF SPINE SPECIALISTS b1b93fe8-adf8-4fd5-9ff0-fda766042ddb Q3 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 400395865 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 2013 third_quarter MED Spinal Cord Injury Funding. HOUSE OF REPRESENTATIVES,SENATE   42867 0 0 2013-10-17T10:54:54.210000-04:00
1446227 FAEGRE DRINKER BIDDLE & REATH LLP 352417d7-f1ce-4169-a334-a0715b589226 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 ALLIANCE FOR BIOSECURITY 2013 third_quarter MED BioShield Project; Biomedical Countermeasures; Biodefense Research and Development Authority; Pandemic and All-Hazards Preparedness Reauthorization (H.R. 2405 and S. 1855) Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 50000   0 0 2013-10-17T11:32:42.410000-04:00
1446294 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE f26bd9db-0b8b-4e90-8eda-24c2982ef219 Q3 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 400382759 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 2013 third_quarter MED Preservation of Antibiotics for Medical Treatment Act--H.R. 1150 HOUSE OF REPRESENTATIVES,SENATE   20777 0 0 2013-10-17T11:48:09.473000-04:00
1446359 TOWNSEND PUBLIC AFFAIRS, INC 931440d9-7a35-4e7a-aca4-76b4fa6bda0c Q3 TOWNSEND PUBLIC AFFAIRS, INC 54734 CITY OF SAN PABLO 2013 third_quarter MED Health/Childhood Obesity Economic Development Administration,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE 15000   0 0 2013-10-17T12:02:34.507000-04:00
1446651 MEHLMAN CONSULTING, INC. 49758ec9-3d7c-4049-9e6d-91a40a9710ae Q3 MEHLMAN CONSULTING, INC. 284950 MAYO CLINIC 2013 third_quarter MED NIH appropriations Clinical laboratory reimbursement Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-17T12:51:31.990000-04:00
1446756 THORN RUN PARTNERS 36ff8f53-5db7-46f9-b3f6-30a6da0c5bdd Q3 THORN RUN PARTNERS 400534596 ABBOTT LABORATORIES 2013 third_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES 40000   0 0 2013-10-17T13:11:10.990000-04:00
1446913 THORN RUN PARTNERS 927ccb04-f196-41be-8fce-e54942220dcf Q3 THORN RUN PARTNERS 400534596 CHILDRENS HOSPITAL COLORADO 2013 third_quarter MED Issues related to clinical research. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-17T13:48:19.257000-04:00
1446979 UNIVERSITY OF KENTUCKY 3a38898a-bb52-4339-bf6a-199d7b1fd245 Q3 UNIVERSITY OF KENTUCKY 400287372 UNIVERSITY OF KENTUCKY 2013 third_quarter MED FY14 funding for NIH, HRSA, CDC, NIOSH HOUSE OF REPRESENTATIVES,SENATE   57000 0 0 2013-10-17T14:01:50.083000-04:00
1447022 IKARIA 9689b3d4-628e-4d79-b067-f50d9ba95480 Q3 IKARIA 400758262 IKARIA 2013 third_quarter MED Funding for rare disease research HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2013-10-17T14:10:09.773000-04:00
1447472 THORN RUN PARTNERS 98ccb0fb-f68e-4015-810e-3284f5b5a6bb Q3 THORN RUN PARTNERS 400534596 NOVARTIS CORPORATION 2013 third_quarter MED Issues related to biologics. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-17T14:59:43.880000-04:00
1447530 PRIME POLICY GROUP a9e4161d-5712-4bff-b4e1-10281841c46f Q3 PRIME POLICY GROUP 400532589 VERAX BIOMEDICAL, INC. 2013 third_quarter MED Blood Safety HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-17T15:05:11.193000-04:00
1447785 THE LIVINGSTON GROUP, LLC bf41954a-0f0b-42c2-b423-400ac5f01f1c Q3 THE LIVINGSTON GROUP, LLC 49635 MAYO CLINIC 2013 third_quarter MED H.R._____, S.3295, FY 2013 Labor-Health and Human Services-Education appropriations bill, National Institutes of Health (NIH) funding; and executive pay scale for extramural NIH researchers. Federal Railroad Administration,HOUSE OF REPRESENTATIVES,Natl Transportation Safety Board (NTSB),SENATE,Transportation, Dept of (DOT) 50000   0 0 2013-10-17T15:32:10.317000-04:00
1448040 LIFE TECHNOLOGIES CORPORATION 1bd63e40-f477-4723-be0d-35b9df946328 Q3 LIFE TECHNOLOGIES CORPORATION 400391833 LIFE TECHNOLOGIES CORPORATION 2013 third_quarter MED H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2013-10-17T15:58:58.717000-04:00
1448350 BAKER BOTTS, L.L.P. 36a1babc-3e5b-456e-871c-5efaec40b2aa Q3 BAKER BOTTS, L.L.P. 5118 SOUTHERN METHODIST UNIVERSITY 2013 third_quarter MED Funding of neurophotonics research for prosthetic devices Army, Dept of (Other),Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2013-10-17T16:23:47.183000-04:00
1448640 THE CORMAC GROUP, LLC 737ba49d-c5d5-4023-87ef-c177ce90219d Q3 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2013 third_quarter MED Appropriations, DOD, TBI research HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-17T17:11:07.323000-04:00
1448647 WINNING STRATEGIES WASHINGTON 1a88f492-567c-46e0-b451-bff1c81d43d4 Q3 WINNING STRATEGIES WASHINGTON 50796 LAHEY HEALTH 2013 third_quarter MED PPACA implementation; nursing education; rural wage index HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-17T17:11:09.777000-04:00
1448745 BRACEWELL LLP 8d713a6a-e70c-4e1b-84ec-4a0e8807139b Q3 BRACEWELL LLP 6837 NATIONAL BRAIN TUMOR SOCIETY 2013 third_quarter MED work related to the advancement of the Cancer Drug Coverage Parity Act of 2013 HOUSE OF REPRESENTATIVES     0 0 2013-10-17T17:29:51.230000-04:00
1448766 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 8372e6c2-53b0-4cfa-9a58-0881c366a35f Q3 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2013 third_quarter MED HR 1098 - Brain Injury Reauthorization Act of 2013: Support passage. S. 1027 - Rehabilitation Research Improvement Act: Advocate to improve coordination and enhance rehabilitation research at the National Institutes of Health. Support passage. HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   110000 0 0 2013-10-17T17:33:58.807000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2138.68ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API